Alterations of the Gut Microbiome Associated With the Treatment of Hyperuricaemia in Male Rats

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2018 Oct 5

PMID 30283432

Citations 51

Authors

Yiran Yu

Qiuping Liu

Haichang Li

Chengping Wen

Zhixing He

Affiliations

Soon will be listed here.

Abstract

Hyperuricaemia is an important risk factor for many diseases including gout, hypertension, and type II diabetes. The gut microbiota is associated with hyperuricaemia and has also been demonstrated to play significant roles in the effects of drug therapy. This study used Illumina MiSeq sequencing to explore alterations of the gut microbiome associated with allopurinol and benzbromarone treatment in the male rat with hyperuricaemia. After drug treatment, both allopurinol and benzbromarone caused an increase of the genera and and a decrease of the genera and . In addition, allopurinol and benzbromarone caused respective unique changes in genera. The genera , , and specifically decreased due to allopurinol treatment. Decreased and and increased were caused by benzbromarone treatment. The PICRUST analysis indicated that allopurinol renovated the disorder of nucleotide metabolism and benzbromarone renovated the disorder of lipid metabolism in the gut microbiota of male rats with hyperuricaemia. These findings demonstrated that the gut microbiota may be altered by the treatment of hyperuricaemia with allopurinol and benzbromarone in male rats. Such alterations of the gut microbiota could be considered as indicators of the effectiveness of drug therapy.

Citing Articles

Jieduquyuziyin prescription attenuates the side effect of prednisone through regulating gut microbiota when in the combination with prednisone treat MRL/lpr mice.

Zhu Z, Wang M, Huang L, He Z J Tradit Complement Med. 2025; 15(2):119-127.

PMID: 40060153 PMC: 11883628. DOI: 10.1016/j.jtcme.2024.05.005.

Elevated uric acid levels, mortality and cognitive impairment in children with severe malaria.

Bond C, Bednarski O, Datta D, Namazzi R, Opoka R, Lima-Cooper G Nat Med. 2025; .

PMID: 39856335 DOI: 10.1038/s41591-024-03430-8.

Taurine alleviates dysfunction of cholesterol metabolism under hyperuricemia by inhibiting A2AR-SREBP-2/CREB/HMGCR axis.

Chen B, Bao R, Pan J, Zhu Z, Chen Q, Wang D J Lipid Res. 2025; 66(2):100746.

PMID: 39848583 PMC: 11875148. DOI: 10.1016/j.jlr.2025.100746.

Elucidating the role of gut microbiota dysbiosis in hyperuricemia and gout: Insights and therapeutic strategies.

Singh A, Durairajan S, Iyaswamy A, Williams L World J Gastroenterol. 2024; 30(40):4404-4410.

PMID: 39494101 PMC: 11525862. DOI: 10.3748/wjg.v30.i40.4404.

Causal effects of gut microbiota on gout and hyperuricemia: insights from genome-wide Mendelian randomization, RNA-sequencing, 16S rRNA sequencing, and metabolomes.

Liu X, Feng Z, Zhang F, Wang B, Wei Z, Liao N Biosci Rep. 2024; 44(11).

PMID: 39492788 PMC: 11598824. DOI: 10.1042/BSR20240595.

References

Mead G . Anaerobic utilization of uric acid by some group D streptococci. J Gen Microbiol. 1974; 82(2):421-3. DOI: 10.1099/00221287-82-2-421. View

Xu K, Xia G, Lu J, Chen M, Zhen X, Wang S . Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients. Sci Rep. 2017; 7(1):1445. PMC: 5431124. DOI: 10.1038/s41598-017-01387-y. View

Talaat K, el-Sheikh A . The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease. Am J Nephrol. 2007; 27(5):435-40. DOI: 10.1159/000105142. View

Edgar R . Search and clustering orders of magnitude faster than BLAST. Bioinformatics. 2010; 26(19):2460-1. DOI: 10.1093/bioinformatics/btq461. View

Kunishima C, Inoue I, Oikawa T, Nakajima H, Komoda T, Katayama S . Activating effect of benzbromarone, a uricosuric drug, on peroxisome proliferator-activated receptors. PPAR Res. 2008; 2007:36092. PMC: 2233808. DOI: 10.1155/2007/36092. View

Feng Z, Long W, Hao B, Ding D, Ma X, Zhao L . A human stool-derived strain caused systemic inflammation in specific-pathogen-free mice. Gut Pathog. 2017; 9:59. PMC: 5657053. DOI: 10.1186/s13099-017-0208-7. View

Halfvarson J, Brislawn C, Lamendella R, Vazquez-Baeza Y, Walters W, Bramer L . Dynamics of the human gut microbiome in inflammatory bowel disease. Nat Microbiol. 2017; 2:17004. PMC: 5319707. DOI: 10.1038/nmicrobiol.2017.4. View

Ogawa Y, Sato M, Yamashita T, Nakano R, Mochizuki S, Kasahara K . Polymicrobial Anaerobic Bacteremia Caused by Butyricimonas virosa and Brachyspira pilosicoli in a Patient with Peritonitis following Intestinal Perforation. Ann Lab Med. 2017; 38(1):71-73. PMC: 5700152. DOI: 10.3343/alm.2018.38.1.71. View

Nieuwdorp M, Gilijamse P, Pai N, Kaplan L . Role of the microbiome in energy regulation and metabolism. Gastroenterology. 2014; 146(6):1525-33. DOI: 10.1053/j.gastro.2014.02.008. View

10.

Jose P, Raj D . Gut microbiota in hypertension. Curr Opin Nephrol Hypertens. 2015; 24(5):403-9. PMC: 4578629. DOI: 10.1097/MNH.0000000000000149. View

11.

Caporaso J, Kuczynski J, Stombaugh J, Bittinger K, Bushman F, Costello E . QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010; 7(5):335-6. PMC: 3156573. DOI: 10.1038/nmeth.f.303. View

12.

Bui T, de Vos W, Plugge C . Anaerostipes rhamnosivorans sp. nov., a human intestinal, butyrate-forming bacterium. Int J Syst Evol Microbiol. 2013; 64(Pt 3):787-793. DOI: 10.1099/ijs.0.055061-0. View

13.

Sorensen L, Levinson D . Origin and extrarenal elimination of uric acid in man. Nephron. 1975; 14(1):7-20. DOI: 10.1159/000180432. View

14.

Krypotou E, Scazzocchio C, Diallinas G . Functional characterization of NAT/NCS2 proteins of Aspergillus brasiliensis reveals a genuine xanthine-uric acid transporter and an intrinsically misfolded polypeptide. Fungal Genet Biol. 2015; 75:56-63. DOI: 10.1016/j.fgb.2015.01.009. View

15.

Marinello E, Pompucci G . [Interrelationship between purine, carbohydrate, lipid and aminoacid metabolism, in hyperuricaemia and gout (author's transl)]. Quad Sclavo Diagn. 1978; 14(1):1-25. View

16.

Kim S, Schneeweiss S, Choudhry N, Liu J, Glynn R, Solomon D . Effects of xanthine oxidase inhibitors on cardiovascular disease in patients with gout: a cohort study. Am J Med. 2015; 128(6):653.e7-653.e16. PMC: 4442710. DOI: 10.1016/j.amjmed.2015.01.013. View

17.

Parks D, Tyson G, Hugenholtz P, Beiko R . STAMP: statistical analysis of taxonomic and functional profiles. Bioinformatics. 2014; 30(21):3123-4. PMC: 4609014. DOI: 10.1093/bioinformatics/btu494. View

18.

Hartstra A, Bouter K, Backhed F, Nieuwdorp M . Insights into the role of the microbiome in obesity and type 2 diabetes. Diabetes Care. 2014; 38(1):159-65. DOI: 10.2337/dc14-0769. View

19.

. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2015; 44(D1):D7-19. PMC: 4702911. DOI: 10.1093/nar/gkv1290. View

20.

Yamada N, Iwamoto C, Kano H, Yamaoka N, Fukuuchi T, Kaneko K . Evaluation of purine utilization by Lactobacillus gasseri strains with potential to decrease the absorption of food-derived purines in the human intestine. Nucleosides Nucleotides Nucleic Acids. 2016; 35(10-12):670-676. DOI: 10.1080/15257770.2015.1125000. View